The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Niraparib and dostarlimab efficacy in patients with platinum-sensitive relapsed mesothelioma: MIST5, a phase IIa clinical trial.
 
Dean Anthony Fennell
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Bristol Myers Squibb; RS Oncology (Inst)
Consulting or Advisory Role - Bristol-Myers Squibb; RS Oncology
Speakers' Bureau - BMS; Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squibb (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Iovance Biotherapeutics (Inst); MSD Oncology (Inst); Owkin (Inst); Roche UK (Inst); RS Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; RS Oncology
 
Amy Branson
No Relationships to Disclose
 
Amy King
No Relationships to Disclose
 
Charlotte Poile
No Relationships to Disclose
 
Shaun Barber
No Relationships to Disclose
 
Marina Antoniou
No Relationships to Disclose
 
Liz Darlison
No Relationships to Disclose
 
Paul Taylor
Stock and Other Ownership Interests - Roche/Genentech
Honoraria - AstraZeneca
Speakers' Bureau - AstraZeneca
Research Funding - Bayer
 
Molly Scotland
No Relationships to Disclose
 
Clare Belcher
No Relationships to Disclose
 
Amrita Bajaj
No Relationships to Disclose
 
Bruno Morgan
No Relationships to Disclose
 
Cassandra Brookes
No Relationships to Disclose
 
Peter Wells-Jordan
No Relationships to Disclose
 
Sean Dulloo
Consulting or Advisory Role - RS Oncology
Travel, Accommodations, Expenses - RS Oncology; SERVIER